Part of the MiphaCare platform · AI-assisted breast imaging
MiPhaWell Breast Intelligence
A second set of eyes for mammography review. Breast Intelligence is designed to highlight regions that deserve a closer look, show why each one was flagged, and keep every final decision with the radiologist.
See how it works ↓From image acquisition to the radiologist's final report.
Developed with support from Providence Health Care · Initial clinical evaluation targeted for early 2027, subject to validation and regulatory authorization.
Synthetic illustration with generated images. Not patient data or model output.
The clinical challenge
Mammography is demanding work, read at scale.
Every screening study deserves the same careful attention, whether it is the first of the day or the last. Breast Intelligence is built around the realities radiologists face.
01
High reading volumes
Screening programs produce long worklists, and every study needs a careful, consistent read.
02
Dense breast tissue
Dense fibroglandular tissue can mask findings, making some mammograms harder to interpret.
03
Subtle findings
Small masses, architectural distortion and fine calcifications can be easy to overlook.
04
Recalls and follow-up
False-positive recalls lead to additional imaging, biopsies and anxiety for patients.
Key capabilities
Built for the reading room.
Breast Intelligence combines a mammography viewer with AI assistance designed to direct attention, explain itself and stay under the radiologist's control.
DICOM mammography viewer
Standard CC and MLO views side by side, with zoom, pan and contrast controls.
AI-assisted region highlighting
Designed to flag mass-like densities, calcification clusters and architectural distortion for review.
Explainable overlays
Attention maps show which image features contributed to each flag, so reviewers see why, not just where.
Radiologist confirmation
Each flag is confirmed or dismissed by the radiologist, who records the final interpretation and BI-RADS category.
Clinician-supervised workflow
AI assists. The radiologist decides.
Breast Intelligence fits into the existing reading workflow. The software highlights; qualified clinicians interpret, decide and report.
01
Acquire
Mammography studies arrive in standard DICOM format.
Imaging system
02
Analyze
MiPhaWell AI models review each view.
Breast Intelligence
03
Highlight
Regions of interest are flagged with explainable overlays.
Breast Intelligence
04
Review
The radiologist confirms or dismisses each flag.
Radiologist
05
Report
The radiologist records the final assessment and recommendations.
Radiologist
Synthetic illustration with generated images. Not patient data or model output.
For healthcare professionals
Designed to support, not replace.
A consistent second lookThe same systematic review on every study, at the start of a shift or the end of it.
Attention where it mattersFlagged regions help focus review time on the areas most worth examining.
Transparent reasoningOverlays show what drew attention, so every flag can be checked against the image.
Clinicians stay in controlNothing is finalized without the radiologist. The software does not diagnose cancer.
Clinical use cases
Where Breast Intelligence is designed to help.
Screening mammography
Second-reader assistance during routine screening reads, highlighting regions for a closer look.
Diagnostic workup
Focused review of flagged regions when patients return for additional imaging.
Quality review and education
Revisiting flagged regions and their overlays for peer review, audit and training.
One connected ecosystem
Part of MiphaCare. Connected to everything MiPhaWell AI builds.
Breast Intelligence brings imaging into the MiphaCare platform, so findings can sit alongside each patient's longitudinal clinical context.
Demonstration video with synthetic data. Not patient data or validated performance.
Development and clinical status
MiPhaWell Breast Intelligence is in the final stages of development, with support from Providence Health Care. Initial clinical evaluation with patients is targeted for early 2027, subject to clinical validation, regulatory authorization and institutional approval.
It is not yet licensed by Health Canada or cleared by the U.S. FDA, and it is not available for clinical use. Images on this page are synthetic illustrations, not patient data or model output.
Questions
Frequently asked questions
Does Breast Intelligence diagnose breast cancer?
No. It is designed to highlight regions for a radiologist to review. Diagnosis, the BI-RADS assessment and all clinical decisions remain with qualified clinicians.
Is it available for clinical use today?
Not yet. Initial clinical evaluation is targeted for early 2027, subject to clinical validation, regulatory authorization and institutional approval.
Are the mammograms on this page real?
No. Every image on this page and in our demonstrations is synthetic. No patient data is shown.
How does it relate to MiphaCare?
Breast Intelligence is the imaging module of the MiphaCare platform. It runs on the MiPhaWell System Layer and is designed so imaging findings can sit alongside a patient's broader clinical context.
Partnerships and clinical collaboration
Explore Breast Intelligence for your organization.
We welcome conversations with hospitals, imaging centers, radiologists, investors and healthcare partners.
